Back to Search Start Over

Author response for 'Helicobacter pylori Eradication by Low‐Dose Rifabutin Triple Therapy (RHB‐105) is Unaffected by High Body Mass Index'

Authors :
Kely L. Sheldon
Dana Portenier
June S. Almenoff
John Y. Kao
Publication Year :
2021
Publisher :
Hindawi Limited, 2021.

Subjects

Subjects :
medicine.medical_specialty
Rifabutin
biology
business.industry
Internal medicine
Low dose
Medicine
Helicobacter pylori
business
biology.organism_classification
Gastroenterology
High body mass index
medicine.drug

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........aefd3749ffacc206077e63182ea11835
Full Text :
https://doi.org/10.1002/ygh2.494/v2/response1
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details